Measure Summaries
The Joint Commission
- Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE during hospitalization (not present at admission) who did not receive VTE prophylaxis between hospital admission and the day before the VTE diagnosis testing order date. This updates a previously published measure summary.
- Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE that are discharged to home, home care, court/law enforcement or home on hospice care on warfarin with written discharge instructions that address all four criteria: compliance issues, dietary advice, follow-up monitoring, and information about the potential for adverse drug reactions/interactions. This updates a previously published measure summary.
- Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE who received an overlap of parenteral (IV or subcu) anticoagulation and warfarin therapy. This updates a previously published measure summary.
- Venous thromboembolism (VTE): percent of patients diagnosed with confirmed VTE who received IV UFH therapy dosages AND had their platelet counts monitored using defined parameters such as a nomogram or protocol. This updates a previously published measure summary.
- Venous thromboembolism (VTE): percent of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission. This updates a previously published measure summary.
- Venous thromboembolism (VTE): percent of patients who received VTE prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after initial admission (or transfer) to the ICU or surgery end date for surgeries that start the day of or the day after ICU admission (or transfer). This updates a previously published measure summary.
No hay comentarios:
Publicar un comentario